Hints and tips:
Related Special Reports
...Ladner said that could make it more effective against a wide range of cancers, including lung, breast, colorectal and prostate as well as ovarian; 5-FU is not currently used for ovarian and prostate cancers...
...For example, he said about 15 to 20 per cent of women in the UK were at high risk for breast cancer because of a combination of genes, and so should be offered mammograms in their 40s, but could not be identified...
...Around 1,000 people in England would be eligible for the treatment each year, according to charity Breast Cancer Now....
...“This is a dark day for people affected by incurable secondary breast cancer....
...Female breast cancer is the most common form of cancer in the UK and accounts for 15 per cent of all new cases, according to the Breast Cancer UK charity....
...Artificial intelligence has the power to sharply cut the number of missed early stage breast cancers, according to research that shows the technology’s potential to improve and accelerate medical diagnoses...
...The paper examined a group of 25,000 women screened for breast cancer in Hungary between 2021 and 2023....
...Other scientists have deployed the technology in an effort to sharply cut the number of missed early-stage breast cancers....
...“There are no awareness campaigns countering this and discussing the health risks of alcohol to women, such as how alcohol causes 10 per cent of breast cancers,” she added....
...Interest in deploying AI in a clinical setting has soared with evidence of its contribution to diagnostics, such as flagging early-stage breast cancers that may be missed by doctors....
...and breast cancer — that showed their new treatment was better than the chemotherapy that doctors have been dependent on for over a decade....
...Earlier this month, Illumina abandoned its appeal of the FTC’s action....
...In October, it announced the outcomes of clinical trials for new treatments for lung and breast cancers — results it hailed as a “massive achievement”....
...She is a shining light for breast cancer sufferers, and on top of that she has had so much to deal with herself. It is quite incredible what she gives to the breast cancer community....
...These include multiple sclerosis medicine Kesimpta, breast cancer drug Kisqali, and Pluvicto, used to treat prostate cancer. Where doubts creep in is how Novartis will replace lost sales from 2027....
...A director of the Child Poverty Action Group, he became Labour MP for Birkenhead on Merseyside in 1979, establishing a reputation as a campaigner against poverty....
...Since his diagnosis for bladder cancer in 2019, Michael Caratti says he has undergone “a 180 degree change in my life”....
...Some PFAS are suspected hormone disrupters and carcinogens, with links to obesity, high blood pressure, fertility issues and cancers of the breast, thyroid and testicles....
...He was the technical lead in chemical development for Truqap, which was approved by the US’s Food and Drug Administration in November to treat some forms of breast cancer....
...Dario Trapani, a doctor at Milan’s European Institute of Oncology, says that when he heard that a drug called paclitaxel, a “backbone for curing women with breast cancer”, was running short in Italy, he...
...It has also settled the three remaining bellwether cases concerning breast cancer in California....
...The US drugmaker, a top-10 pharma company by sales, relies on WuXi AppTec sister company WuXi Biologics to manufacture some of the active pharmaceutical ingredients in its blockbuster cancer pill Revlimid...
...I am reluctant at first — after a brush with breast cancer, I was advised to avoid saunas....
...Breast cancer accounted for the highest number of “early onset” cases in 2019....
...Research using Biobank data has already helped identify genes offering protection against obesity and diabetes, as well as others that raise risks of heart disease, breast cancer and prostate cancer....
International Edition